China - Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses - Market Analysis, Forecast, Size, Trends And Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingPrice for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in China - 2023
Contents:
- Price for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in China (FOB) - 2023
- Price for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in China (CIF) - 2022
- Exports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in China
- Imports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in China
Price for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in China (FOB) - 2023
The average export price for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses stood at $18,389 per ton in September 2023, with a decrease of -5.4% against the previous month. Overall, the export price, however, showed a relatively flat trend pattern. The pace of growth appeared the most rapid in March 2023 an increase of 14% m-o-m. Over the period under review, the average export prices attained the maximum at $21,008 per ton in April 2023; however, from May 2023 to September 2023, the export prices remained at a lower figure.
There were significant differences in the average prices for the major export markets. In September 2023, the country with the highest price was India ($56,267 per ton), while the average price for exports to Malaysia ($6,043 per ton) was amongst the lowest.
From September 2022 to September 2023, the most notable rate of growth in terms of prices was recorded for supplies to Brazil (+1.9%), while the prices for the other major destinations experienced more modest paces of growth.
Price for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in China (CIF) - 2022
In 2022, the average import price for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses amounted to $68,438 per ton, declining by -32.1% against the previous year. Over the period under review, the import price recorded a abrupt contraction. The pace of growth was the most pronounced in 2017 when the average import price increased by 44% against the previous year. As a result, import price reached the peak level of $408,692 per ton. From 2018 to 2022, the average import prices remained at a lower figure.
There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Sweden ($672,510 per ton), while the price for India ($11,976 per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by South Africa (+2.9%), while the prices for the other major suppliers experienced a decline.
Exports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in China
In 2022, the amount of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses exported from China soared to 28K tons, picking up by 24% on the previous year. The total export volume increased at an average annual rate of +6.5% from 2019 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. The growth pace was the most rapid in 2020 with an increase of 25% against the previous year. As a result, the exports attained the peak of 29K tons. From 2021 to 2022, the growth of the exports of remained at a somewhat lower figure.
In value terms, exports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses skyrocketed to $514M in 2022. In general, total exports indicated a resilient expansion from 2019 to 2022: its value increased at an average annual rate of +14.1% over the last three years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, exports increased by +48.4% against 2019 indices. As a result, the exports attained the peak and are likely to continue growth in the immediate term.
| Export of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in China (Million USD) | |||||
|---|---|---|---|---|---|
| COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
| India | 71.9 | 79.4 | 75.9 | 128 | 21.2% |
| United States | 41.0 | 70.1 | 67.0 | 79.0 | 24.4% |
| Brazil | 20.3 | 23.5 | 20.5 | 36.2 | 21.3% |
| Japan | 26.9 | 29.0 | 27.8 | 29.7 | 3.4% |
| Colombia | 6.8 | 9.7 | 18.7 | 17.8 | 37.8% |
| Spain | 10.9 | 10.9 | 8.5 | 15.3 | 12.0% |
| Mexico | 11.2 | 11.6 | 10.4 | 15.1 | 10.5% |
| South Korea | 11.4 | 11.7 | 11.5 | 13.5 | 5.8% |
| Thailand | 3.8 | 3.3 | 3.5 | 9.9 | 37.6% |
| Algeria | 3.3 | 2.3 | 5.7 | 9.3 | 41.3% |
| Argentina | 3.3 | 6.4 | 6.6 | 8.3 | 36.0% |
| Malaysia | 3.5 | 3.0 | 2.5 | 8.2 | 32.8% |
| Canada | 5.9 | 5.7 | 6.2 | 7.8 | 9.8% |
| Others | 126 | 126 | 121 | 136 | 2.6% |
| Total | 346 | 392 | 386 | 514 | 14.1% |
Top Export Markets for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses from China in 2022:
- United States (7.3K tons)
- India (2.0K tons)
- Brazil (1.6K tons)
- Colombia (1.5K tons)
- Spain (1.3K tons)
- Mexico (1.1K tons)
- Malaysia (0.9K tons)
- Thailand (0.8K tons)
- South Korea (0.8K tons)
- Algeria (0.7K tons)
- Japan (0.7K tons)
- Argentina (0.7K tons)
- Canada (0.6K tons)
Imports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in China
In 2022, the amount of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses imported into China soared to 5.8K tons, increasing by 58% compared with the previous year's figure. In general, imports saw a significant expansion. The growth pace was the most rapid in 2021 when imports increased by 132%. Imports peaked in 2022 and are expected to retain growth in the near future.
In value terms, imports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses totaled $399M in 2022. Overall, total imports indicated a prominent expansion from 2019 to 2022: its value increased at an average annual rate of +12.2% over the last three-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports increased by +45.1% against 2020 indices. The growth pace was the most rapid in 2021 with an increase of 35% against the previous year. Imports peaked in 2022 and are expected to retain growth in the immediate term.
| Import of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in China (Million USD) | |||||
|---|---|---|---|---|---|
| COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
| France | 32.7 | 45.0 | 86.4 | 128 | 57.6% |
| Italy | 59.0 | 63.9 | 106 | 99.9 | 19.2% |
| Netherlands | 44.1 | 9.6 | 40.8 | 34.7 | -7.7% |
| Belgium | 16.4 | 17.7 | 18.3 | 21.0 | 8.6% |
| South Africa | N/A | 12.9 | 13.1 | 18.6 | 20.1% |
| Slovenia | 3.8 | 2.3 | 6.6 | 9.1 | 33.8% |
| Norway | N/A | 2.6 | 9.0 | 7.0 | 64.1% |
| India | 0.9 | 2.3 | 0.6 | 1.7 | 23.6% |
| Others | 125 | 119 | 90.5 | 79.0 | -14.2% |
| Total | 282 | 275 | 371 | 399 | 12.3% |
Top Suppliers of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses to China in 2022:
- France (2211.5 tons)
- Italy (2136.2 tons)
- South Africa (323.0 tons)
- Slovenia (292.7 tons)
- Norway (191.9 tons)
- India (138.3 tons)
- Netherlands (124.7 tons)
- Belgium (111.0 tons)
This report provides an in-depth analysis of the market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses in China. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201320 - Other medicaments for therapeutic or prophylactic uses, of HS
Country coverage:
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in China
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
224
This report provides an in-depth analysis of the market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses in China.
343
This report provides an in-depth analysis of the medicaments containing hormones market in China.
341
This report provides an in-depth analysis of the medicaments containing insulin market in China.
365
This report provides an in-depth analysis of the medicaments containing penicillin market in China.
229
This report provides an in-depth analysis of the market for medicaments of alkaloids or derivatives thereof in China.
236
This report provides an in-depth analysis of the market for medicaments of other antibiotics in China.
308
This report provides an in-depth analysis of the global market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses.
485
This report provides an in-depth analysis of the global medicaments containing hormones market.
479
This report provides an in-depth analysis of the global medicaments containing insulin market.
579
This report provides an in-depth analysis of the global medicaments containing penicillin market.
101
Explore the top 10 import markets for non-antibiotic, non-hormone, non-alkaloid medicaments based on the latest data. Discover the key countries driving the demand for therapeutic and prophylactic medicaments.
101
Explore the top 10 import markets for non-antibiotic, non-hormone, non-alkaloid medicaments based on the latest data. Discover the key countries driving the demand for therapeutic and prophylactic medicaments.
